More on DMAC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

DiaMedica Therapeutics Inc. (NQ:DMAC)
Delayed: 8.74 +0.02 (0.23%)
Prev. Close $8.72  
Open$8.77 
52 Wk High$ 
52 Wk Low$ 
Day High$8.92 
Day Low$8.56 
P/E N/A  
EPS$ 
Volume129,605 


Oct 22, 2026 08:00 AM DiaMedica hits 200-patient mark in stroke trial, interim analysis due
Oct 22, 2026 08:00 AM DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
Oct 19, 2026 08:00 AM DiaMedica Therapeutics Provides Update on Fetal Growth Restriction Key Opinion Leader Webinar
Sep 30, 2026 08:30 AM DiaMedica to present early Phase 2 FGR trial data at Oct. 23 webinar
Sep 30, 2026 08:30 AM DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results
Aug 12, 2026 04:24 PM Form 4 DiaMedica Therapeutics For: Aug 10 Filed by: Pauls Dietrich John
Aug 11, 2026 08:46 AM Form S-8 DiaMedica Therapeutics
Aug 10, 2026 05:36 PM DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q2 EPS
Aug 10, 2026 04:38 PM Form 10-Q DiaMedica Therapeutics For: Jun 30
Aug 10, 2026 04:36 PM Form 8-K DiaMedica Therapeutics For: Aug 10
View All Articles

Entities mentioned with DMAC

View All Entities